These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15622663

  • 1. The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain.
    Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC.
    J Am Dent Assoc; 2004 Nov; 135(11):1578-90. PubMed ID: 15622663
    [Abstract] [Full Text] [Related]

  • 2. Single doses of parecoxib sodium intravenously are as effective as ketorolac in reducing pain after oral surgery.
    Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC.
    J Oral Maxillofac Surg; 2003 Sep; 61(9):1030-7. PubMed ID: 12966478
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model.
    Daniels SE, Grossman EH, Kuss ME, Talwalker S, Hubbard RC.
    Clin Ther; 2001 Jul; 23(7):1018-31. PubMed ID: 11519767
    [Abstract] [Full Text] [Related]

  • 4. Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty.
    Malan TP, Marsh G, Hakki SI, Grossman E, Traylor L, Hubbard RC.
    Anesthesiology; 2003 Apr; 98(4):950-6. PubMed ID: 12657858
    [Abstract] [Full Text] [Related]

  • 5. The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively.
    Desjardins PJ, Grossman EH, Kuss ME, Talwalker S, Dhadda S, Baum D, Hubbard RC.
    Anesth Analg; 2001 Sep; 93(3):721-7. PubMed ID: 11524347
    [Abstract] [Full Text] [Related]

  • 6. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model.
    Malmstrom K, Fricke JR, Kotey P, Kress B, Morrison B.
    Clin Ther; 2002 Oct; 24(10):1549-60. PubMed ID: 12462285
    [Abstract] [Full Text] [Related]

  • 7. The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials.
    Morrison BW, Fricke J, Brown J, Yuan W, Kotey P, Mehlisch D.
    J Am Dent Assoc; 2000 Dec; 131(12):1729-37. PubMed ID: 11143737
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery.
    Barton SF, Langeland FF, Snabes MC, LeComte D, Kuss ME, Dhadda SS, Hubbard RC.
    Anesthesiology; 2002 Aug; 97(2):306-14. PubMed ID: 12151917
    [Abstract] [Full Text] [Related]

  • 9. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
    Malmstrom K, Sapre A, Couglin H, Agrawal NG, Mazenko RS, Fricke JR.
    Clin Ther; 2004 May; 26(5):667-79. PubMed ID: 15220011
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.
    Ott E, Nussmeier NA, Duke PC, Feneck RO, Alston RP, Snabes MC, Hubbard RC, Hsu PH, Saidman LJ, Mangano DT, Multicenter Study of Perioperative Ischemia (McSPI) Research Group, Ischemia Research and Education Foundation (IREF) Investigators.
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1481-92. PubMed ID: 12830070
    [Abstract] [Full Text] [Related]

  • 11. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor.
    Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, Cippolle M, Schuller R, Cheung RY, Fort JG.
    Anesth Analg; 2004 Feb; 98(2):336-342. PubMed ID: 14742366
    [Abstract] [Full Text] [Related]

  • 12. Valdecoxib versus rofecoxib in acute postsurgical pain: results of a randomized controlled trial.
    Christensen KS, Cawkwell GD.
    J Pain Symptom Manage; 2004 May; 27(5):460-70. PubMed ID: 15120774
    [Abstract] [Full Text] [Related]

  • 13. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.
    Morrison BW, Christensen S, Yuan W, Brown J, Amlani S, Seidenberg B.
    Clin Ther; 1999 Jun; 21(6):943-53. PubMed ID: 10440619
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
    Moberly JB, Xu J, Desjardins PJ, Daniels SE, Bandy DP, Lawson JE, Link AJ, Truitt KE.
    Clin Ther; 2007 Mar; 29(3):399-412. PubMed ID: 17577461
    [Abstract] [Full Text] [Related]

  • 15. The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery.
    Malan TP, Gordon S, Hubbard R, Snabes M.
    Anesth Analg; 2005 Feb; 100(2):454-460. PubMed ID: 15673875
    [Abstract] [Full Text] [Related]

  • 16. Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain.
    Zuniga JR, Phillips CL, Shugars D, Lyon JA, Peroutka SJ, Swarbrick J, Bon C.
    J Oral Maxillofac Surg; 2004 Jul; 62(7):806-15. PubMed ID: 15218558
    [Abstract] [Full Text] [Related]

  • 17. A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy.
    Bikhazi GB, Snabes MC, Bajwa ZH, Davis DJ, LeComte D, Traylor L, Hubbard RC.
    Am J Obstet Gynecol; 2004 Oct; 191(4):1183-91. PubMed ID: 15507939
    [Abstract] [Full Text] [Related]

  • 18. Intravenous parecoxib sodium foracute pain after orthopedic knee surgery.
    Rasmussen GL, Steckner K, Hogue C, Torri S, Hubbard RC.
    Am J Orthop (Belle Mead NJ); 2002 Jun; 31(6):336-43. PubMed ID: 12083587
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of the first parenteral selective COX-2 inhibitor, parecoxib sodium, in adult patients with postoperative pain.
    Samra SS, Shah RR, Jagtap SA, Bajaj P, Vyas D, Ram S, Kale S, Vijayakrishnan M, Neelakandan RS, Lall AD, Jain MM, Naikawadi AA, Kadam GS, Dongre N, Ballary C, Desai A.
    J Indian Med Assoc; 2003 Jul; 101(7):439-42. PubMed ID: 14748383
    [Abstract] [Full Text] [Related]

  • 20. Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo.
    Harris SI, Kuss M, Hubbard RC, Goldstein JL.
    Clin Ther; 2001 Sep; 23(9):1422-8. PubMed ID: 11589257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.